Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial.

Rahimi A, Mohamad O, Albuquerque K, Kim DWN, Chen D, Thomas K, Wooldridge R, Rivers A, Leitch M, Rao R, Haley B, Ahn C, Garwood D, Spangler A.

Support Care Cancer. 2019 Jul 4. doi: 10.1007/s00520-019-04957-0. [Epub ahead of print]

PMID:
31273506
2.

Mammographic density changes in surgical weight loss-an indication for personalized screening.

Partain N, Mokdad A, Puzziferri N, Porembka J, Seiler S, Christie A, Farr D, Rivers A, Marilyn Leitch A, Wooldridge R, Huth J, Rao R.

BMC Med Imaging. 2018 May 9;18(1):10. doi: 10.1186/s12880-017-0242-4.

3.

Bracketed radioactive seed localization vs bracketed wire-localization in breast surgery.

Da Silva M, Porembka J, Mokdad AA, Seiler S, Huth J, Rivers A, Wooldridge R, Chu A, Brown E, Bao J, Farr D, Hansen M, Unzeitig-Barron A, Leitch M, Rao R.

Breast J. 2018 Mar;24(2):161-166. doi: 10.1111/tbj.12854. Epub 2017 Jul 14.

PMID:
28707718
4.

Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation.

Rahimi A, Thomas K, Spangler A, Rao R, Leitch M, Wooldridge R, Rivers A, Seiler S, Albuquerque K, Stevenson S, Goudreau S, Garwood D, Haley B, Euhus D, Heinzerling J, Ding C, Gao A, Ahn C, Timmerman R.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):196-205.e2. doi: 10.1016/j.ijrobp.2017.01.020. Epub 2017 Jan 12.

5.

Genetic Ancestry using Mitochondrial DNA in patients with Triple-negative breast cancer (GAMiT study).

Rao R, Rivers A, Rahimi A, Wooldridge R, Rao M, Leitch M, Euhus D, Haley BB.

Cancer. 2017 Jan 1;123(1):107-113. doi: 10.1002/cncr.30267. Epub 2016 Sep 1.

6.

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

Rugo HS, Olopade OI, DeMichele A, Yau C, van 't Veer LJ, Buxton MB, Hogarth M, Hylton NM, Paoloni M, Perlmutter J, Symmans WF, Yee D, Chien AJ, Wallace AM, Kaplan HG, Boughey JC, Haddad TC, Albain KS, Liu MC, Isaacs C, Khan QJ, Lang JE, Viscusi RK, Pusztai L, Moulder SL, Chui SY, Kemmer KA, Elias AD, Edmiston KK, Euhus DM, Haley BB, Nanda R, Northfelt DW, Tripathy D, Wood WC, Ewing C, Schwab R, Lyandres J, Davis SE, Hirst GL, Sanil A, Berry DA, Esserman LJ; I-SPY 2 Investigators.

N Engl J Med. 2016 Jul 7;375(1):23-34. doi: 10.1056/NEJMoa1513749.

7.

Adaptive Randomization of Neratinib in Early Breast Cancer.

Park JW, Liu MC, Yee D, Yau C, van 't Veer LJ, Symmans WF, Paoloni M, Perlmutter J, Hylton NM, Hogarth M, DeMichele A, Buxton MB, Chien AJ, Wallace AM, Boughey JC, Haddad TC, Chui SY, Kemmer KA, Kaplan HG, Isaacs C, Nanda R, Tripathy D, Albain KS, Edmiston KK, Elias AD, Northfelt DW, Pusztai L, Moulder SL, Lang JE, Viscusi RK, Euhus DM, Haley BB, Khan QJ, Wood WC, Melisko M, Schwab R, Helsten T, Lyandres J, Davis SE, Hirst GL, Sanil A, Esserman LJ, Berry DA; I-SPY 2 Investigators.

N Engl J Med. 2016 Jul 7;375(1):11-22. doi: 10.1056/NEJMoa1513750.

8.

Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancer.

Bao J, Borja N, Rao M, Huth J, Leitch AM, Rivers A, Wooldridge R, Rao R.

Cancer Med. 2015 Apr;4(4):500-6. doi: 10.1002/cam4.388. Epub 2015 Jan 30.

9.

Office ductoscopy for surgical selection in women with pathologic nipple discharge.

Khan SA, Mangat A, Rivers A, Revesz E, Susnik B, Hansen N.

Ann Surg Oncol. 2011 Dec;18(13):3785-90. doi: 10.1245/s10434-011-1791-3. Epub 2011 May 28.

PMID:
21626081
10.

Strategies for reducing cancer incidence and mortality in African American and Arab American and Chaldean communities in the Detroit metropolitan area.

Vicini FA, Shah C, Wallace M, Jones P, Dykes V, Tull J, Akhtar A, Ballouz S, Boxwala I, Douglas-Nikitin V, Rivers A, Clark R, Jaiyesimi I, Fakhouri M.

Am J Clin Oncol. 2012 Aug;35(4):316-21. doi: 10.1097/COC.0b013e318210f9b5.

PMID:
21587031
11.

Differences in disease presentation, management techniques, treatment outcome, and toxicities in African-American women with early stage breast cancer treated with breast-conserving therapy.

Vicini F, Jones P, Rivers A, Wallace M, Mitchell C, Kestin L, Jaiyesimi I, Dekhne N, Martinez A.

Cancer. 2010 Jul 15;116(14):3485-92. doi: 10.1002/cncr.25088.

12.

Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge.

Fackler MJ, Rivers A, Teo WW, Mangat A, Taylor E, Zhang Z, Goodman S, Argani P, Nayar R, Susnik B, Sukumar S, Khan SA.

Clin Cancer Res. 2009 Jun 1;15(11):3802-11. doi: 10.1158/1078-0432.CCR-08-1981. Epub 2009 May 26.

13.

Axillary management after sentinel lymph node biopsy in breast cancer patients.

Rivers A, Hansen N.

Surg Clin North Am. 2007 Apr;87(2):365-77, ix. Review.

PMID:
17498532
14.

Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.

Rivers AK, Griffith KA, Hunt KK, Degnim AC, Sabel MS, Diehl KM, Cimmino VM, Chang AE, Lucas PC, Newman LA.

Ann Surg Oncol. 2006 Jan;13(1):36-44. Epub 2006 Jan 1.

15.

Ductal lavage for breast cancer risk assessment.

Rivers A, Newman LA.

Surg Oncol Clin N Am. 2005 Jan;14(1):45-68, vi. Review.

PMID:
15541999

Supplemental Content

Loading ...
Support Center